Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11839604
Use of sublingual dexmedetomidine for the treatment of agitation
granted -
US 11839594
Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride
granted -
US 11839629
Methods and compositions to modulate hair growth
granted -
US 11840688
Compositions and methods for inhibiting gene expression of Hif2alpha
granted -
US 11840575
Engineered immune cells targeting BCMA and their uses thereof
granted -
US 11840686
Modulation of prekallikrein (PKK) expression
granted -
US 11839676
System, method, and kit for selecting and preparing customized cosmetics
granted -
US 11839631
Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cells
granted -
US 11839596
Treatment of vasculopathy with prostacyclin and mesenchymal stem cells
granted -
US 11840497
4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
granted -
US 11839649
Compositions comprising recombinant probiotic bacteria and methods of use thereof
granted -
US 11840704
Adeno-associated virus variant capsids and methods of use thereof
granted -
CN 117186084
Pranlerivir sulfonate, and pharmaceutical preparation, preparation method and application thereof in treatment of herpes virus
granted -
WO 2023232958
INHIBITEURS DE LA KINASE DE BRUTON POUR LE TRAITEMENT D'UNE RÉACTION ALLERGIQUE SOUDAINE
granted -
US 11833130
Treatment of circadian rhythm disorders
granted -
US 11832924
Fluorescence imaging processing and computation for surgery
granted -
US 11833171
Materials and methods relating to stabilised polymeric silicate compositions
granted -
US 11833136
Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs
granted -
US 11833148
Methods for treating or limiting development of cardiovascular disease-related neurological disorders
granted -
US 11833168
Compounds and methods for increasing STMN2 expression
granted -
US 11833160
Ursodeoxycholic acid derivatives as HDAC inhibitors for the treatment of polycystic diseases
granted -
US 11833210
ASH1L inhibitors and methods of treatment therewith
granted -
US 11833211
Methods of suppression and treatment of disease comprising administering bicycle peptide ligands specific for EphA2
granted -
US 11833199
Peptide fragments from filoviruses and their uses
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.